6-1610850-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001453.3(FOXC1):c.405C>T(p.Cys135Cys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00585 in 1,614,076 control chromosomes in the GnomAD database, including 384 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.029 ( 187 hom., cov: 31)
Exomes 𝑓: 0.0035 ( 197 hom. )
Consequence
FOXC1
NM_001453.3 synonymous
NM_001453.3 synonymous
Scores
1
1
Clinical Significance
Conservation
PhyloP100: 2.75
Publications
3 publications found
Genes affected
FOXC1 (HGNC:3800): (forkhead box C1) This gene belongs to the forkhead family of transcription factors which is characterized by a distinct DNA-binding forkhead domain. The specific function of this gene has not yet been determined; however, it has been shown to play a role in the regulation of embryonic and ocular development. Mutations in this gene cause various glaucoma phenotypes including primary congenital glaucoma, autosomal dominant iridogoniodysgenesis anomaly, and Axenfeld-Rieger anomaly. [provided by RefSeq, Jul 2008]
FOXC1 Gene-Disease associations (from GenCC):
- anterior segment dysgenesis 3Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
- Axenfeld-Rieger syndrome type 3Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
- aniridiaInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- Axenfeld anomalyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Axenfeld-Rieger syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- isolated aniridiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Peters anomalyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Rieger anomalyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.51).
BP6
Variant 6-1610850-C-T is Benign according to our data. Variant chr6-1610850-C-T is described in CliVar as Benign. Clinvar id is 167085.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-1610850-C-T is described in CliVar as Benign. Clinvar id is 167085.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.75 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0946 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FOXC1 | NM_001453.3 | c.405C>T | p.Cys135Cys | synonymous_variant | Exon 1 of 1 | ENST00000645831.2 | NP_001444.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0285 AC: 4336AN: 152092Hom.: 183 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
4336
AN:
152092
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00793 AC: 1993AN: 251402 AF XY: 0.00583 show subpopulations
GnomAD2 exomes
AF:
AC:
1993
AN:
251402
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00349 AC: 5096AN: 1461868Hom.: 197 Cov.: 32 AF XY: 0.00309 AC XY: 2246AN XY: 727236 show subpopulations
GnomAD4 exome
AF:
AC:
5096
AN:
1461868
Hom.:
Cov.:
32
AF XY:
AC XY:
2246
AN XY:
727236
show subpopulations
African (AFR)
AF:
AC:
3563
AN:
33480
American (AMR)
AF:
AC:
274
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
AC:
10
AN:
26136
East Asian (EAS)
AF:
AC:
0
AN:
39700
South Asian (SAS)
AF:
AC:
77
AN:
86258
European-Finnish (FIN)
AF:
AC:
0
AN:
53402
Middle Eastern (MID)
AF:
AC:
60
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
675
AN:
1112004
Other (OTH)
AF:
AC:
437
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
346
691
1037
1382
1728
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
130
260
390
520
650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0286 AC: 4353AN: 152208Hom.: 187 Cov.: 31 AF XY: 0.0269 AC XY: 2004AN XY: 74410 show subpopulations
GnomAD4 genome
AF:
AC:
4353
AN:
152208
Hom.:
Cov.:
31
AF XY:
AC XY:
2004
AN XY:
74410
show subpopulations
African (AFR)
AF:
AC:
4031
AN:
41514
American (AMR)
AF:
AC:
196
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
AC:
2
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5158
South Asian (SAS)
AF:
AC:
3
AN:
4828
European-Finnish (FIN)
AF:
AC:
0
AN:
10604
Middle Eastern (MID)
AF:
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
AC:
63
AN:
68008
Other (OTH)
AF:
AC:
54
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
195
390
585
780
975
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
46
92
138
184
230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
28
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Apr 28, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Axenfeld-Rieger syndrome type 3 Benign:1
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Uncertain
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.